143 related articles for article (PubMed ID: 25055123)
1. PDK1: a new therapeutic target for glioblastoma?
Velpula KK; Tsung AJ
CNS Oncol; 2014 May; 3(3):177-9. PubMed ID: 25055123
[No Abstract] [Full Text] [Related]
2. Combined PDK1 and CHK1 inhibition is required to kill glioblastoma stem-like cells in vitro and in vivo.
Signore M; Pelacchi F; di Martino S; Runci D; Biffoni M; Giannetti S; Morgante L; De Majo M; Petricoin EF; Stancato L; Larocca LM; De Maria R; Pallini R; Ricci-Vitiani L
Cell Death Dis; 2014 May; 5(5):e1223. PubMed ID: 24810059
[TBL] [Abstract][Full Text] [Related]
3. Genetic and pharmacological inhibition of PDK1 in cancer cells: characterization of a selective allosteric kinase inhibitor.
Nagashima K; Shumway SD; Sathyanarayanan S; Chen AH; Dolinski B; Xu Y; Keilhack H; Nguyen T; Wiznerowicz M; Li L; Lutterbach BA; Chi A; Paweletz C; Allison T; Yan Y; Munshi SK; Klippel A; Kraus M; Bobkova EV; Deshmukh S; Xu Z; Mueller U; Szewczak AA; Pan BS; Richon V; Pollock R; Blume-Jensen P; Northrup A; Andersen JN
J Biol Chem; 2011 Feb; 286(8):6433-48. PubMed ID: 21118801
[TBL] [Abstract][Full Text] [Related]
4. Akt is efficiently activated by PIF-pocket- and PtdIns(3,4,5)P3-dependent mechanisms leading to resistance to PDK1 inhibitors.
Najafov A; Shpiro N; Alessi DR
Biochem J; 2012 Dec; 448(2):285-95. PubMed ID: 23030823
[TBL] [Abstract][Full Text] [Related]
5. A key role for mitochondrial gatekeeper pyruvate dehydrogenase in oncogene-induced senescence.
Kaplon J; Zheng L; Meissl K; Chaneton B; Selivanov VA; Mackay G; van der Burg SH; Verdegaal EM; Cascante M; Shlomi T; Gottlieb E; Peeper DS
Nature; 2013 Jun; 498(7452):109-12. PubMed ID: 23685455
[TBL] [Abstract][Full Text] [Related]
6. PI3 kinase directly phosphorylates Akt1/2 at Ser473/474 in the insulin signal transduction pathway.
Tsuchiya A; Kanno T; Nishizaki T
J Endocrinol; 2014 Jan; 220(1):49-59. PubMed ID: 24169049
[TBL] [Abstract][Full Text] [Related]
7. PDK1 inhibition is a novel therapeutic target in multiple myeloma.
Fujiwara S; Kawano Y; Yuki H; Okuno Y; Nosaka K; Mitsuya H; Hata H
Br J Cancer; 2013 Jan; 108(1):170-8. PubMed ID: 23321518
[TBL] [Abstract][Full Text] [Related]
8. Chemical biology: Caught in the activation.
Liu Y
Nature; 2009 Sep; 461(7263):484-5. PubMed ID: 19779441
[No Abstract] [Full Text] [Related]
9. Discovery of a Potent Allosteric Kinase Modulator by Combining Computational and Synthetic Methods.
Kroon E; Schulze JO; Süß E; Camacho CJ; Biondi RM; Dömling A
Angew Chem Int Ed Engl; 2015 Nov; 54(47):13933-6. PubMed ID: 26385475
[TBL] [Abstract][Full Text] [Related]
10. PDK1 and SGK3 Contribute to the Growth of BRAF-Mutant Melanomas and Are Potential Therapeutic Targets.
Scortegagna M; Lau E; Zhang T; Feng Y; Sereduk C; Yin H; De SK; Meeth K; Platt JT; Langdon CG; Halaban R; Pellecchia M; Davies MA; Brown K; Stern DF; Bosenberg M; Ronai ZA
Cancer Res; 2015 Apr; 75(7):1399-412. PubMed ID: 25712345
[TBL] [Abstract][Full Text] [Related]
11. Combined targeting of PDK1 and EGFR triggers regression of glioblastoma by reversing the Warburg effect.
Velpula KK; Bhasin A; Asuthkar S; Tsung AJ
Cancer Res; 2013 Dec; 73(24):7277-89. PubMed ID: 24148623
[TBL] [Abstract][Full Text] [Related]
12. Development of the First Generation of Disulfide-Based Subtype-Selective and Potent Covalent Pyruvate Dehydrogenase Kinase 1 (PDK1) Inhibitors.
Liu Y; Xie Z; Zhao D; Zhu J; Mao F; Tang S; Xu H; Luo C; Geng M; Huang M; Li J
J Med Chem; 2017 Mar; 60(6):2227-2244. PubMed ID: 28230989
[TBL] [Abstract][Full Text] [Related]
13. Targeting pyruvate dehydrogenase kinase signaling in the development of effective cancer therapy.
Anwar S; Shamsi A; Mohammad T; Islam A; Hassan MI
Biochim Biophys Acta Rev Cancer; 2021 Aug; 1876(1):188568. PubMed ID: 34023419
[TBL] [Abstract][Full Text] [Related]
14. Design and synthesis of 2-oxindole based multi-targeted inhibitors of PDK1/Akt signaling pathway for the treatment of glioblastoma multiforme.
Sestito S; Nesi G; Daniele S; Martelli A; Digiacomo M; Borghini A; Pietra D; Calderone V; Lapucci A; Falasca M; Parrella P; Notarangelo A; Breschi MC; Macchia M; Martini C; Rapposelli S
Eur J Med Chem; 2015 Nov; 105():274-88. PubMed ID: 26498573
[TBL] [Abstract][Full Text] [Related]
15. Identification of pyruvate dehydrogenase kinase 1 inhibitors with anti-osteosarcoma activity.
Fang A; Luo H; Liu L; Fan H; Zhou Y; Yao Y; Zhang Y
Bioorg Med Chem Lett; 2017 Dec; 27(24):5450-5453. PubMed ID: 29150396
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of pyruvate dehydrogenase kinase improves pulmonary arterial hypertension in genetically susceptible patients.
Michelakis ED; Gurtu V; Webster L; Barnes G; Watson G; Howard L; Cupitt J; Paterson I; Thompson RB; Chow K; O'Regan DP; Zhao L; Wharton J; Kiely DG; Kinnaird A; Boukouris AE; White C; Nagendran J; Freed DH; Wort SJ; Gibbs JSR; Wilkins MR
Sci Transl Med; 2017 Oct; 9(413):. PubMed ID: 29070699
[TBL] [Abstract][Full Text] [Related]
17. The PDK1 master kinase is over-expressed in acute myeloid leukemia and promotes PKC-mediated survival of leukemic blasts.
Zabkiewicz J; Pearn L; Hills RK; Morgan RG; Tonks A; Burnett AK; Darley RL
Haematologica; 2014 May; 99(5):858-64. PubMed ID: 24334295
[TBL] [Abstract][Full Text] [Related]
18. Liquid Chromatography-Tandem Mass Spectrometry Method Revealed that Lung Cancer Cells Exhibited Distinct Metabolite Profiles upon the Treatment with Different Pyruvate Dehydrogenase Kinase Inhibitors.
Zhang W; Hu X; Zhou W; Tam KY
J Proteome Res; 2018 Sep; 17(9):3012-3021. PubMed ID: 30028142
[TBL] [Abstract][Full Text] [Related]
19. Diversity of the pyruvate dehydrogenase kinase gene family in humans.
Gudi R; Bowker-Kinley MM; Kedishvili NY; Zhao Y; Popov KM
J Biol Chem; 1995 Dec; 270(48):28989-94. PubMed ID: 7499431
[TBL] [Abstract][Full Text] [Related]
20. Development of actionable targets of multi-kinase inhibitors (AToMI) screening platform to dissect kinase targets of staurosporines in glioblastoma cells.
Denisova OV; Merisaari J; Kaur A; Yetukuri L; Jumppanen M; von Schantz-Fant C; Ohlmeyer M; Wennerberg K; Aittokallio T; Taipale M; Westermarck J
Sci Rep; 2022 Aug; 12(1):13796. PubMed ID: 35963891
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
